A detailed history of Group One Trading, L.P. transactions in Ac Immune Sa stock. As of the latest transaction made, Group One Trading, L.P. holds 19,397 shares of ACIU stock, worth $59,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,397
Previous 451 4200.89%
Holding current value
$59,936
Previous $1,000 7600.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.29 - $4.87 $43,386 - $92,267
18,946 Added 4200.89%
19,397 $77,000
Q1 2024

May 10, 2024

BUY
$2.66 - $4.87 $1,199 - $2,196
451 New
451 $1,000
Q3 2023

Nov 09, 2023

BUY
$2.77 - $3.38 $6,213 - $7,581
2,243 Added 74.47%
5,255 $14,000
Q2 2023

Aug 09, 2023

BUY
$1.85 - $3.4 $5,572 - $10,240
3,012 New
3,012 $8,000
Q3 2021

Nov 12, 2021

SELL
$6.2 - $8.34 $34,577 - $46,512
-5,577 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$6.04 - $8.37 $33,685 - $46,679
5,577 New
5,577 $44,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $258M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.